Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis

Completed · Phase 3 · Has a placebo group

Conditions studied: Lupus Nephritis

In brief

The purpose of this study is to evaluate the efficacy, safety, and tolerability of belimumab in adult patients with active lupus nephritis.

Key facts

Study ID

NCT01639339

Run by

Human Genome Sciences Inc., a GSK Company

People needed

448

Starts

2012-07-12

Expected to finish

2020-03-12

Last updated by the study team

2021-03-19

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• GSK Investigational Site — San Leandro, California, United States
• GSK Investigational Site — Torrance, California, United States
• GSK Investigational Site — Gainesville, Florida, United States
• GSK Investigational Site — Miami, Florida, United States
• GSK Investigational Site — St Louis, Missouri, United States
• GSK Investigational Site — Brooklyn, New York, United States
• GSK Investigational Site — Great Neck, New York, United States
• GSK Investigational Site — Manhasset, New York, United States
• GSK Investigational Site — New York, New York, United States
• GSK Investigational Site — New York, New York, United States
• GSK Investigational Site — Chapel Hill, North Carolina, United States
• GSK Investigational Site — Columbus, Ohio, United States
• GSK Investigational Site — Bethlehem, Pennsylvania, United States
• GSK Investigational Site — Philadelphia, Pennsylvania, United States
• GSK Investigational Site — Charleston, South Carolina, United States
• GSK Investigational Site — Onalaska, Wisconsin, United States
• GSK Investigational Site — Ciudad Autonoma Buenos Aires, Buenos Aires, Argentina
• GSK Investigational Site — San Miguel de Tucumán, Tucumán Province, Argentina
• GSK Investigational Site — Buenos Aires, Argentina
• GSK Investigational Site — Ciudad Autonoma Buenos Aires, Argentina
• GSK Investigational Site — Córdoba, Argentina
• GSK Investigational Site — Mendoza, Argentina
• GSK Investigational Site — Brussels, Belgium
• GSK Investigational Site — Brussels, Belgium
• GSK Investigational Site — La Palma, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.